title: Transcatheter aortic valve replacement.
abstract: The percutaneous transcatheter aortic valve replacement (TAVR) procedure, introduced in 2002, has emerged as a successful and comparable treatment option for many patients with aortic stenosis. Balanced general anesthesia or monitored anesthesia care in addition to local anesthesia have been used during transfemoral and transapical approaches. The results of different TAVR registries and the PARTNER trial have shown excellent success and survival rates, but stroke and paravalvular insufficiency represent major concerns. The key for successful procedural outcome involves thorough preparedness and knowledge of the pertinent procedural details.
authors.affiliation: Cardiothoracic Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. alfirea@ccf.org
authors.forename: Andrej
authors.initials: A
authors.lastname: Alfirevic
authors.forename: Anand R
authors.initials: AR
authors.lastname: Mehta
authors.forename: Lars G
authors.initials: LG
authors.lastname: Svensson
mesh_terms: D000758:Anesthesia / Q000379:methods; D001021:Aortic Valve / Q000601:surgery*; D000075202:Contraindications; D017548:Echocardiography, Transesophageal; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology; D020521:Stroke / Q000209:etiology